133 related articles for article (PubMed ID: 2614505)
1. Antibacterial activity of the sulbactam-ampicillin combination.
Sessarego FV; Botta GA; Pesce A; Schito GC
J Chemother; 1989 Dec; 1(6):384-7. PubMed ID: 2614505
[TBL] [Abstract][Full Text] [Related]
2. [A combination of ampicillin and sulbactam: effect on aerobic and anaerobic gram-negative bacteria].
González C; García A; Urrea R; del Solar E; Bello H; Zemelman R
Rev Med Chil; 1990 May; 118(5):548-54. PubMed ID: 2293275
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity against clinically important gram-positive and gram-negative bacteria of sulbactam, alone and in combination with ampicillin, cefotaxime, mezlocillin, and piperacillin.
Schmalreck AF; Wildfeuer A
Arzneimittelforschung; 1990 Oct; 40(10):1145-55. PubMed ID: 2291754
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of sulbactam/ampicillin against ampicillin-resistant, beta-lactamase-producing bacteria isolated in Italian hospitals.
Varaldo PE; Ripa S; Nicoletti G; Covelli I; Satta G; Carlone N; Fontana R
Chemotherapy; 1990; 36(2):141-6. PubMed ID: 2178890
[TBL] [Abstract][Full Text] [Related]
5. Tazobactam-piperacillin compared with sulbactam-ampicillin, clavulanic acid-ticarcillin, sulbactam-cefoperazone, and piperacillin for activity against beta-lactamase-producing bacteria isolated from patients with complicated urinary tract infections.
Nomura S; Hanaki H; Nagayama A
J Chemother; 1997 Apr; 9(2):89-94. PubMed ID: 9176745
[TBL] [Abstract][Full Text] [Related]
6. [Mechanism of drug resistance of carbapenems-resistant Acinetobacter baumannii and the application of a combination of drugs in vitro].
Zhao C; Xie W; Zhang W; Ye Z; Wu H
Zhonghua Shao Shang Za Zhi; 2014 Apr; 30(2):166-70. PubMed ID: 24989663
[TBL] [Abstract][Full Text] [Related]
7. Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.
Sader HS; Tosin I; Sejas L; Miranda E
Braz J Infect Dis; 2000 Feb; 4(1):22-8. PubMed ID: 10788842
[TBL] [Abstract][Full Text] [Related]
8. [Synergy between sulbactam and ampicillin or cefoperazone in antimicrobial activity against beta-lactamase producing microorganisms. Results with the use of microdilution broth method].
Deguchi K; Yokota N; Koguchi M; Nakane Y; Fukushima Y; Fukayama S; Ishihara R; Oda S; Tanaka S; Sato K
Jpn J Antibiot; 1990 Jul; 43(7):1214-24. PubMed ID: 2232151
[TBL] [Abstract][Full Text] [Related]
9. [Comparison of the in vitro activity of amoxycillin + clavulanic acid and ampicillin + sulbactam combinations against 50 Haemophilus influenzae strains producing beta lactamase].
Moittie D; Simonet M; Veron M
Pathol Biol (Paris); 1989 May; 37(5):390-3. PubMed ID: 2789362
[TBL] [Abstract][Full Text] [Related]
10. [Antimicrobial activities of sultamicillin against clinical isolates obtained from outpatients].
Deguchi K; Yokota N; Koguchi M; Suzuki Y; Fukayama S; Ishihara R; Oda S
Jpn J Antibiot; 1993 Sep; 46(9):781-93. PubMed ID: 8254898
[TBL] [Abstract][Full Text] [Related]
11. [Beta-lactamase distribution among pathogenic microorganisms. The antibacterial action of a combined preparation of ampicillin/sulbactam (Unasyn)].
Akar ZhF
Antibiot Khimioter; 1991 Jun; 36(6):5-8. PubMed ID: 1898192
[No Abstract] [Full Text] [Related]
12. A multicentre study to evaluate the effect of sulbactam/ampicillin combination on anaerobic micro-organisms.
Leone F; Morandotti MG; Mazzella P; Sanna A; Ravizzola G; Colombrita D; Pinzi G; Turano R; Menozzi MG; Lecchini R
J Int Med Res; 1990; 18(3):191-200. PubMed ID: 2193834
[TBL] [Abstract][Full Text] [Related]
13. Implications of beta-lactamase-inhibitor combinations.
Fuchs PC; Barry AL
J Reprod Med; 1990 Mar; 35(3 Suppl):317-21. PubMed ID: 2319514
[TBL] [Abstract][Full Text] [Related]
14. Comparative in vitro activities of amoxicillin-clavulanate, ampicillin-sulbactam and piperacillin-tazobactam against strains of Escherichia coli and proteus mirabilis harbouring known beta-lactamases.
Gatermann S; Marre R
Infection; 1991; 19(2):106-9. PubMed ID: 1646771
[TBL] [Abstract][Full Text] [Related]
15. A multicenter international study on the activity of sulbactam/ampicillin, ampicillin, and cefoxitin against anaerobic bacteria and introduction of a new model of susceptibility testing in mixed infections.
Heizmann WR; Heilmann F; Werner H
Suppl Int J Gynecol Obstet; 1989; 2():7-12; discussion 47-8. PubMed ID: 2679683
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of sulbactam in an in vitro model of mixed aerobic/anaerobic infections.
Heizmann WR; Heilmann F; Egeler B; Werner H
Infection; 1990; 18(2):117-21. PubMed ID: 2332245
[TBL] [Abstract][Full Text] [Related]
17. Microbiological properties of sulbactam combined with ampicillin.
Barba D; Galante D; Esposito S; Ruffilli MP
Chemioterapia; 1987 Apr; 6(2):88-94. PubMed ID: 3036381
[TBL] [Abstract][Full Text] [Related]
18. [Antimicrobial activity of sultamicillin against clinical isolates from upper respiratory tract infections II].
Deguchi K; Yokota N; Koguchi M; Nakane Y; Fukayama S; Nishimura Y; Oda S; Tanaka S; Kato M; Sato K
Jpn J Antibiot; 1988 Dec; 41(12):2065-74. PubMed ID: 3266883
[TBL] [Abstract][Full Text] [Related]
19. In-vitro activity of ampicillin/sulbactam and other antibiotics against clinical isolates of Haemophilus sp. and Branhamella catarrhalis.
Stefani S; Russo G; Pellegrino MB; Mezzatesta ML; Cocuzza C; Nicoletti G
J Chemother; 1990 Feb; 2(1):26-30. PubMed ID: 2110245
[TBL] [Abstract][Full Text] [Related]
20. Effect of beta-lactamase inhibitors on minimum inhibitory concentration of ampicillin and amoxicillin for Staphylococcus aureus strains.
Paniagua GL; Monroy E; García O; Vaca S
Rev Latinoam Microbiol; 1998; 40(3-4):128-34. PubMed ID: 10932741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
